SCHEMBL30200828

SCHEMBL30200828

CCC(CC)Cn1ncc(B2OC(C)(C)C(C)(C)O2)c1C

nearest known ligand 0.42

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
UCHL1 P09936 1/20 0.42
FFAR1 O14842 1/20 0.34
LPL P06858 1/20 0.30
LIPG Q9Y5X9 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30201150 0.85 UCHL1 (0.41) UCHL1FFAR1
SCHEMBL18125399 0.84 UCHL1 (0.45) UCHL1FFAR1LPLLIPG
SCHEMBL1358786 0.80 UCHL1 (0.41) UCHL1FFAR1
SCHEMBL25428252 0.80 UCHL1 (0.43) UCHL1FFAR1
SCHEMBL21266884 0.78 UCHL1 (0.43) UCHL1FFAR1
SCHEMBL30200601 0.78 FFAR1 (0.43) UCHL1FFAR1
SCHEMBL30508697 0.77 UCHL1 (0.40) UCHL1FFAR1
SCHEMBL21266730 0.76 UCHL1 (0.38) UCHL1FFAR1
SCHEMBL24896720 0.75 UCHL1 (0.44) UCHL1FFAR1
SCHEMBL25428501 0.75 UCHL1 (0.39) UCHL1FFAR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4401729-A1 BCL-XL DEGRADERS AND USES THEREOF Kymera Therapeutics, Inc. (US) 2024-07-24 EP disclosed
WO-2023044046-A1 BCL-XL DEGRADERS AND USES THEREOF KYMERA THERAPEUTICS, INC. (US) 2023-03-23 WO disclosed